Regeneron Pharmaceuticals Inc
Stock Chart, Company Information, and Scan Results
$785.38(as of Feb 6, 3:59 PM EST)
Stock Market Guides is not a financial advisor. Our content is strictly educational and should not be considered financial advice.
Regeneron Pharmaceuticals Inc Company Information, Fundamentals, and Technical Indicators
Stock Price$785.38
Ticker SymbolREGN
ExchangeNasdaq
SectorHealthcare
IndustryBiotechnology
Employees15,222
CountyUSA
Market Cap$81,048.0M
EBIDTA4,245.7M
10-Day Moving Average761.73
P/E Ratio18.74
20-Day Moving Average758.10
Forward P/E Ratio17.61
50-Day Moving Average758.71
Earnings per Share41.47
200-Day Moving Average622.67
Profit Margin21.74%
RSI59.49
Shares Outstanding103.9M
ATR22.57
52-Week High821.11
Volume670,808
52-Week Low475.17
Book Value31,256.9M
P/B Ratio2.70
Upper Keltner808.88
P/S Ratio5.89
Lower Keltner707.33
Debt-to-Equity Ratio808.88
Next Earnings DateUnknown
Cash Surplus-2,716.1M
Next Ex-Dividend Date02/20/2026
Looking for a prescription for success? Then this could be the stock for you. Regeneron is at the forefront of biotechnology that develops and commercializes life-transforming medicines. They are best known for their blockbuster drug Eylea, which is used to treat age-related macular degeneration—a leading cause of blindness in the elderly.
Regeneron Pharmaceuticals Inc In Our Stock Scanner
As of Feb 06, 2026
Scan Name: Increasing Book ValueScan Type: Stock Fundamentals
As of ---
Scan Name: Low Debt to Equity RatioScan Type: Stock Fundamentals
As of ---
Join Our Free Email List
Get emails from us about ways to potentially make money in the stock market.